Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have prostacyclin receptor activity. Involved in several processes, including negative regulation of platelet-derived growth factor receptor signaling pathway; negative regulation of smooth muscle cell proliferation; and response to lipopolysaccharide. Predicted to localize to cytosol and plasma membrane. Is expressed in several structures, including alimentary system; gallbladder; genitourinary system; hemolymphoid system gland; and limb segment. Orthologous to human PTGIR (prostaglandin I2 receptor).